Report cover image

Nasal Dressings Market (Product Type: Non-biodegradable Nasal Dressings and Biodegradable Nasal Dressings; Material: Chitosan Lactate & Chitosan Hydrochloride, Polyvinyl Alcohol/Polyvinyl Acetate & Polyethylene Glycol, Cellulose & Carboxymethyl Cellulose,

Publisher Transparency Market Research Pvt. Ltd.
Published May 10, 2022
Length 203 Pages
SKU # TNPR17326537

Description

Nasal Dressings Market (Product Type: Non-biodegradable Nasal Dressings and Biodegradable Nasal Dressings; Material: Chitosan Lactate & Chitosan Hydrochloride, Polyvinyl Alcohol/Polyvinyl Acetate & Polyethylene Glycol, Cellulose & Carboxymethyl Cellulose, Hyaluronic Acid, and Synthetic Polyurethane Foam) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Companies Mentioned

Anika Therapeutics, Inc.
Datt Mediproducts Private Limited
First Aid Bandage Company (FABCO)
Lohmann & Rauscher GmbH & Co. KG
Medtronic plc
Olympus Corporation
Smith & Nephew plc
Stryker Corporation
Summit Medical LLC (Innovia Medical)

Countries

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Forecast Year (first) - 2021

Forecast Year (last) - 2031

Forecast Year ( first)  Value - 1.1

Forecast Year (last) Value - 2.7

CAGR % - 0.0901

Currency - US$ Bn

Table of Contents

203 Pages
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nasal Dressings Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Nasal Dressings Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Pricing Analysis
5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
5.4. Regulatory scenario, by Region/Globally
5.5. Global Tenders for Nasal Dressing Market
6. Global Nasal Dressings Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Non-biodegradable (conventional) Nasal Dressings
6.3.2. Biodegradable (bioresorbable and biofragmentable) Nasal Dressings
6.4. Market Attractiveness Analysis, by Product Type
7. Global Nasal Dressings Market Analysis and Forecast, by Material
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Material, 2017–2031
7.3.1. Chitosan Lactate & Chitosan Hydrochloride
7.3.2. Polyvinyl Alcohol (PVA)/Polyvinyl Acetate (PVAc) & Polyethylene Glycol (PEG)
7.3.3. Cellulose & Carboxymethyl Cellulose (CMC)
7.3.4. Hyaluronic Acid (HA)
7.3.5. Synthetic Polyurethane Foam (SPF)
7.4. Market Attractiveness Analysis, by Material
8. Global Nasal Dressings Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Wound Care
8.3.2. Epistaxis Management
8.3.3. Hemostatic Control
8.3.4. Rhinoplasty
8.3.5. Septoplasty
8.3.6. Sinus Surgery
8.3.7. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Nasal Dressings Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals & Clinics
9.3.2. Ambulatory Surgery Centers
9.3.3. Home Care Settings
9.4. Market Attractiveness Analysis, by End-user
10. Global Nasal Dressings Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America Nasal Dressings Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Non-biodegradable (conventional) Nasal Dressings
11.2.2. Biodegradable (bioresorbable and biofragmentable) Nasal Dressings
11.3. Market Value Forecast, by Material, 2017–2031
11.3.1. Chitosan Lactate & Chitosan Hydrochloride
11.3.2. Polyvinyl Alcohol (PVA)/Polyvinyl Acetate (PVAc) & Polyethylene Glycol (PEG)
11.3.3. Cellulose & Carboxymethyl Cellulose (CMC)
11.3.4. Hyaluronic Acid (HA)
11.3.5. Synthetic Polyurethane Foam (SPF)
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Wound Care
11.4.2. Epistaxis Management
11.4.3. Hemostatic Control
11.4.4. Rhinoplasty
11.4.5. Septoplasty
11.4.6. Sinus Surgery
11.4.7. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals & Clinics
11.5.2. Ambulatory Surgery Centers
11.5.3. Home Care Settings
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Material
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Nasal Dressings Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Non-biodegradable (conventional) Nasal Dressings
12.2.2. Biodegradable (bioresorbable and biofragmentable) Nasal Dressings
12.3. Market Value Forecast, by Material, 2017–2031
12.3.1. Chitosan Lactate & Chitosan Hydrochloride
12.3.2. Polyvinyl Alcohol (PVA)/Polyvinyl Acetate (PVAc) & Polyethylene Glycol (PEG)
12.3.3. Cellulose & Carboxymethyl Cellulose (CMC)
12.3.4. Hyaluronic Acid (HA)
12.3.5. Synthetic Polyurethane Foam (SPF)
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Wound Care
12.4.2. Epistaxis Management
12.4.3. Hemostatic Control
12.4.4. Rhinoplasty
12.4.5. Septoplasty
12.4.6. Sinus Surgery
12.4.7. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals & Clinics
12.5.2. Ambulatory Surgery Centers
12.5.3. Home Care Settings
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Material
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Nasal Dressings Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Non-biodegradable (conventional) Nasal Dressings
13.2.2. Biodegradable (bioresorbable and biofragmentable) Nasal Dressings
13.3. Market Value Forecast, by Material, 2017–2031
13.3.1. Chitosan Lactate & Chitosan Hydrochloride
13.3.2. Polyvinyl Alcohol (PVA)/Polyvinyl Acetate (PVAc) & Polyethylene Glycol (PEG)
13.3.3. Cellulose & Carboxymethyl Cellulose (CMC)
13.3.4. Hyaluronic Acid (HA)
13.3.5. Synthetic Polyurethane Foam (SPF)
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Wound Care
13.4.2. Epistaxis Management
13.4.3. Hemostatic Control
13.4.4. Rhinoplasty
13.4.5. Septoplasty
13.4.6. Sinus Surgery
13.4.7. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals & Clinics
13.5.2. Ambulatory Surgery Centers
13.5.3. Home Care Settings
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Material
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Nasal Dressings Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Non-biodegradable (conventional) Nasal Dressings
14.2.2. Biodegradable (bioresorbable and biofragmentable) Nasal Dressings
14.3. Market Value Forecast, by Material, 2017–2031
14.3.1. Chitosan Lactate & Chitosan Hydrochloride
14.3.2. Polyvinyl Alcohol (PVA)/Polyvinyl Acetate (PVAc) & Polyethylene Glycol (PEG)
14.3.3. Cellulose & Carboxymethyl Cellulose (CMC)
14.3.4. Hyaluronic Acid (HA)
14.3.5. Synthetic Polyurethane Foam (SPF)
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Wound Care
14.4.2. Epistaxis Management
14.4.3. Hemostatic Control
14.4.4. Rhinoplasty
14.4.5. Septoplasty
14.4.6. Sinus Surgery
14.4.7. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals & Clinics
14.5.2. Ambulatory Surgery Centers
14.5.3. Home Care Settings
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Material
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Nasal Dressings Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2017–2031
15.2.1. Non-biodegradable (conventional) Nasal Dressings
15.2.2. Biodegradable (bioresorbable and biofragmentable) Nasal Dressings
15.3. Market Value Forecast, by Material, 2017–2031
15.3.1. Chitosan Lactate & Chitosan Hydrochloride
15.3.2. Polyvinyl Alcohol (PVA)/Polyvinyl Acetate (PVAc) & Polyethylene Glycol (PEG)
15.3.3. Cellulose & Carboxymethyl Cellulose (CMC)
15.3.4. Hyaluronic Acid (HA)
15.3.5. Synthetic Polyurethane Foam (SPF)
15.4. Market Value Forecast, by Application, 2017–2031
15.4.1. Wound Care
15.4.2. Epistaxis Management
15.4.3. Hemostatic Control
15.4.4. Rhinoplasty
15.4.5. Septoplasty
15.4.6. Sinus Surgery
15.4.7. Others
15.5. Market Value Forecast, by End-user, 2017–2031
15.5.1. Hospitals & Clinics
15.5.2. Ambulatory Surgery Centers
15.5.3. Home Care Settings
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Material
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Region/Global
16.3. Company Profiles
16.3.1. Anika Therapeutics, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Datt Mediproducts Private Limited
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. SWOT Analysis
16.3.2.4. Strategic Overview
16.3.3. First Aid Bandage Company (FABCO)
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. SWOT Analysis
16.3.4. Lohmann & Rauscher GmbH & Co. KG
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. SWOT Analysis
16.3.5. Medtronic plc
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Olympus Corporation
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Smith & Nephew plc
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Stryker Corporation
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Summit Medical LLC (Innovia Medical)
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. SWOT Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us